| Raegan McClain |
Raegan McClain is currently the Chief Compliance Officer at Oyster Point Pharma, Inc. She has an undergraduate degree from The Pennsylvania State University and a graduate degree from the University of Pittsburgh Law School. |
| George Donato |
George Donato is currently working as Senior Vice President-Operations & CMC at Oyster Point Pharma, Inc. He previously worked as Senior Vice President-Operations at Iroko Pharmaceuticals, Inc. He completed his undergraduate degree and MBA from Widener University. |
| Marian Macsai |
Marian Macsai is a Clinical Professor at Pritzker School of Medicine. She is also the Chief Medical Officer & Head-Medical Affairs at Oyster Point Pharma, Inc. since 2020. Previously, she served as the Chairman of Eye Bank Association of America, Head-Ophthalmology Division at Endeavor Health LLC, Professor-Ophthalmology at Feinberg School of Medicine, and President of Cornea Society, Inc. |
| Eric Carlson |
Eric Carlson is currently the Chief Scientific Officer at Oyster Point Pharma, Inc. Prior to this, he was the Chief Scientific Officer & Executive VP at Akorn, Inc. and Vice President-Research & Development at Aerie Pharmaceuticals, Inc. He also served as the Head-Therapeutic Unit at Alcon Laboratories, Inc. and as a Principal at Novartis Pharmaceuticals Corp. In addition, he was a Member-Governors Board at ARVO Foundation for Eye Research. Carlson received his undergraduate degree from Thiel College and his doctorate from The University of Cincinnati College of Medicine. |
| Daniel Lochner |
Daniel Lochner is currently the Chief Financial & Business Officer at Oyster Point Pharma, Inc. He previously worked as a Portfolio Manager at Goldman Sachs Asset Management LP from 2005 to 2019. Mr. Lochner holds an MBA from The Trustees of Columbia University in The City of New York and an undergraduate degree from the University of Richmond. |
